If you have any questions about our products or services, please fill out the message below and we will give you feedback as soon as possible.
Ramucirumab (LY3009806, IMC-1121B, trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment ofsolid tumors. This drug was developed by ImClone Systems Inc.